REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Lekarna V Aleji S.R.O. (Czech Republic)

Main Activities: Pharmacies and Drug Stores | Department Stores
Full name: Lekarna V Aleji S.R.O. Profile Updated: November 30, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Lekarna V Aleji S.R.O. is based in Czech Republic. The head office is in Podebrady. The company operates in the Pharmacies and Drug Stores industry. The company was established on July 11, 2013. 10 - 19 (2025) employees currently work for Lekarna V Aleji S.R.O.. The company’s latest financial report indicates a net sales revenue increase of 10.05% in 2024. Its’ total assets recorded a growth of 18.85%. The net profit margin of Lekarna V Aleji S.R.O. decreased by 13.29% in 2024.

Headquarters
Cechova 1431
Podebrady; Stredocesky; Postal Code: 29001

Contact Details: Purchase the Lekarna V Aleji S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Lekarna V Aleji S.R.O. report to view the information.
Registered Capital:
Purchase the Lekarna V Aleji S.R.O. report to view the information.
Financial Auditors:
Purchase the Lekarna V Aleji S.R.O. report to view the information.
Incorporation Date:
July 11, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Lekarna V Aleji S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
10.05%▲
Total operating revenue
9.82%▲
Operating profit (EBIT)
-92.11%▼
EBITDA
-80.94%▼
Net Profit (Loss) for the Period
-99.56%▼
Total Assets
18.85%▲
Total Equity
0.2%▲
Operating Profit Margin (ROS)
-16.53%▼
Net Profit Margin
-13.29%▼
Return on Equity (ROE)
-44.53%▼
Debt/Equity
-2.19%▼
Quick Ratio
0.18%▲
Cash Ratio
-0.02%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo